Compound Detail
CHEMBL26
SULPIRIDE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL26 |
| Name | SULPIRIDE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | BGRJTUBHPOOWDU-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
33
Targets
175
Activities
3
Assay Types
8
PK Parameters
20
Publications
26
Known Names
5
Indications
1
Mechanisms
Molecular Properties
341.4
MW (Da)
0.56
ALogP
5
HBA
2
HBD
101.7
PSA (Ų)
0.79
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dopamine D2 receptor antagonist | ANTAGONIST | D(2) dopamine receptor | ✓ | ✓ |
Indications
Psychotic Disorders Anxiety Dementia Depressive Disorder Schizophrenia
ATC Classification
N05AL01
sulpiride
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Activity Summary
Ki 154 meas. best 9.1
IC50 18 meas. best 7.99
Kd 3 meas. best 8.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Carbonic anhydrase 6 CHEMBL3025 | Ki | 9.1 | 9.1 | 0.8 | 3 |
| D(2) dopamine receptor CHEMBL339 | Kd | 8.82 | 8.82 | 1.5 | 1 |
| D(2) dopamine receptor CHEMBL217 | Kd | 8.55 | 8.55 | 2.8 | 1 |
| Carbonic anhydrase 7 CHEMBL2326 | Ki | 8.44 | 6.44 | 3.6 | 3 |
| Carbonic anhydrase 12 CHEMBL3242 | Ki | 8.41 | 8.41 | 3.9 | 3 |
| D(2) dopamine receptor CHEMBL339 | Ki | 8.26 | 7.44 | 5.5 | 2 |
| D(2) dopamine receptor CHEMBL217 | Ki | 8.12 | 7.555 | 7.6 | 4 |
| D(3) dopamine receptor CHEMBL234 | Ki | 8.1 | 7.42 | 8.0 | 3 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 7.99 | 7.3533 | 10.3 | 3 |
| Carbonic anhydrase 5B, mitochondrial CHEMBL3969 | Ki | 7.75 | 7.75 | 18.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 7.72 | 6.3322 | 19.0 | 37 |
| AGAP002992-PA CHEMBL3399914 | Ki | 7.53 | 7.53 | 29.5 | 1 |
| Carbonic anhydrase 9 CHEMBL3594 | Ki | 7.51 | 7.374 | 31.0 | 5 |
| D(2) dopamine receptor CHEMBL339 | IC50 | 7.48 | 7.0575 | 33.0 | 4 |
| D(3) dopamine receptor CHEMBL234 | Kd | 7.4 | 7.4 | 39.8 | 1 |
| Carbonic anhydrase 1 CHEMBL261 | IC50 | 7.4 | 6.66 | 40.0 | 2 |
| Carbonic anhydrase 2 CHEMBL205 | Ki | 7.4 | 7.4 | 40.0 | 38 |
| Carbonic anhydrase 2 CHEMBL205 | IC50 | 7.4 | 7.4 | 40.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 7.18 | 6.84 | 66.2 | 4 |
| Carbonate dehydratase CHEMBL3745586 | Ki | 7.17 | 7.17 | 67.4 | 1 |
| Carbonic anhydrase 15 CHEMBL5973 | Ki | 7.14 | 7.14 | 73.0 | 1 |
| Carbonic anhydrase CHEMBL6185 | Ki | 6.95 | 6.95 | 113.0 | 1 |
| Carbonic anhydrase CHEMBL5931 | Ki | 6.91 | 6.91 | 124.0 | 1 |
| Carbonic anhydrase 5A, mitochondrial CHEMBL4789 | Ki | 6.76 | 6.76 | 174.0 | 1 |
| Carbonic anhydrase CHEMBL4211 | Ki | 6.75 | 6.72 | 179.0 | 2 |
| D(2) dopamine receptor CHEMBL2703 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| Delta carbonic anhydrase CHEMBL3097982 | Ki | 6.59 | 6.59 | 259.0 | 1 |
| Carbonic anhydrase 2 CHEMBL6068 | Ki | 6.58 | 6.58 | 266.0 | 1 |
| Astrosclerin-3 CHEMBL1944499 | Ki | 6.42 | 6.42 | 378.0 | 1 |
| Carbonic anhydrase CHEMBL1649055 | Ki | 6.38 | 6.38 | 415.0 | 1 |
| Alpha carbonic anhydrase CHEMBL1075028 | Ki | 6.37 | 6.37 | 430.0 | 2 |
| Carbonic anhydrase 4 CHEMBL281 | IC50 | 6.21 | 6.21 | 620.0 | 1 |
| Carbonic anhydrase CHEMBL5337 | Ki | 6.12 | 6.12 | 760.0 | 2 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 6.12 | 6.12 | 757.0 | 1 |
| Carbonic anhydrase 2 CHEMBL1697676 | Ki | 6.09 | 6.09 | 812.0 | 1 |
| Carbonic anhydrase, alpha family CHEMBL3621035 | Ki | 6.06 | 6.06 | 873.0 | 1 |
| Carbonic anhydrase 1 CHEMBL261 | Ki | 5.92 | 5.6388 | 1200.0 | 32 |
| Dopamine receptor CHEMBL2093868 | Ki | 5.8 | 5.8 | 1600.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | IC50 | 5.7 | 5.7 | 2019.0 | 1 |
| D(4) dopamine receptor CHEMBL219 | Ki | 5.68 | 5.68 | 2100.0 | 1 |
| Beta-carbonic anhydrase 1 CHEMBL5631 | Ki | 5.64 | 5.64 | 2300.0 | 1 |
| Carbonic anhydrase 3 CHEMBL2885 | Ki | 4.97 | 4.97 | 10600.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 1.83 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.83 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.1 | mL.min-1.kg-1 | Homo sapiens |
| F | 49.0 | % | Homo sapiens |
| F | 36.0 | % | Homo sapiens |
| Fu | 0.72 | - | Homo sapiens |
| Fu | 0.63 | - | Rattus norvegicus |
| Fu | 0.24 | - | Sus scrofa |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885861 | Rattus norvegicus | 1377 |
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 467 |
| - | 10.5281/zenodo.13943903 | ADMET | 89 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 15658873 | 10.1021/jm049711o | ADMET | 5 |
| 26832216 | 10.1016/j.bmcl.2016.01.023 | Unchecked | 4 |
| 25129169 | 10.1016/j.bmc.2014.07.048 | Unchecked | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 24792813 | 10.1016/j.bmc.2014.04.006 | Unchecked | 3 |
| 17228881 | 10.1021/jm0612057 | Unchecked | 3 |
| 26174556 | 10.1016/j.bmcl.2015.06.079 | Unchecked | 3 |
| 25773015 | 10.1016/j.bmc.2015.02.045 | Unchecked | 3 |
| 15801855 | 10.1021/jm040889k | Rattus norvegicus | 3 |
| 2522993 | 10.1021/jm00124a024 | D(2) dopamine receptor | 3 |
| 6128419 | 10.1021/jm00353a003 | Rattus norvegicus | 3 |
| 11384238 | 10.1021/jm001101a | Homo sapiens | 3 |
| 10841786 | 10.1021/jm991156g | Liposome | 2 |
| 19445515 | 10.1021/jm900403j | Homo sapiens | 2 |
Data from ChEMBL 36 via Core Engine